Abdelhamid M, Jung CG, Zhou C, Abdullah M, Nakano M, Wakabayashi H, Abe F, Michikawa M (2020) Dietary lactoferrin supplementation prevents memory impairment and reduces amyloid-β generation in J20 mice. J Alzheimers Dis 74:245–259
Article CAS PubMed Google Scholar
Ahmad J, Singhal M, Amin S, Rizwanullah M, Akhter S, Amjad Kamal M, Haider N, Midoux P, Pichon C (2017) Bile salt stabilized vesicles (bilosomes): a novel nano-pharmaceutical design for oral delivery of proteins and peptides. Curr Pharm Des 23:1575–1588
Article CAS PubMed Google Scholar
Almeida AJ, Souto E (2007) Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev 59:478–490
Article CAS PubMed Google Scholar
Andreani T, de Souza AL, Kiill CP, Lorenzon EN, Fangueiro JF, Calpena AC, Chaud MV, Garcia ML, Gremiao MP, Silva AM, Souto EB (2014) Preparation and characterization of PEG-coated silica nanoparticles for oral insulin delivery. Int J Pharm 473:627–635
Article CAS PubMed Google Scholar
Bahman F, Taurin S, Altayeb D, Taha S, Bakhiet M, Greish K (2020) Oral insulin delivery using poly (styrene co-maleic acid) micelles in a diabetic mouse model. Pharmaceutics 12:1026
Article CAS PubMed PubMed Central Google Scholar
Bennett PH (2018) Diabetes mortality in the USA: winning the battle but not the war? Lancet 391:2392–2393
Bernkop-Schnürch A, Jalil A (2018) Do drug release studies from SEDDS make any sense? J Control Release 271:55–59
Blanco-Llamero C, Fonseca J, Durazzo A, Lucarini M, Santini A, Senorans FJ, Souto EB (2022) Nutraceuticals and food-grade lipid nanoparticles: from natural sources to a circular bioeconomy approach. Foods 11:2318
Article CAS PubMed PubMed Central Google Scholar
Caffarel-Salvador E, Abramson A, Langer R, Traverso G (2017) Oral delivery of biologics using drug-device combinations. Curr Opin Pharmacol 36:8–13
Article CAS PubMed PubMed Central Google Scholar
Cao J, Huang D, Peppas NA (2020) Advanced engineered nanoparticulate platforms to address key biological barriers for delivering chemotherapeutic agents to target sites. Adv Drug Deliv Rev 167:170–188
Article CAS PubMed Google Scholar
Cholkar K, Patel A, Dutt Vadlapudi A, Mitra K (2012) Novel nanomicellar formulation approaches for anterior and posterior segment ocular drug delivery. Recent Patents Nanomed 2:82–95
Chu C, Deng Y, Liu H, Wei M, Xu X, Gou J, He H, Yin T, Zhang Y, Tang X (2023) In situ rearranged multifunctional lipid nanoparticles via synergistic potentiation for oral insulin delivery. Int J Pharm 636:122811
Article CAS PubMed Google Scholar
Creemers JHA, Pawlitzky I, Grosios K, Gileadi U, Middleton MR, Gerritsen WR, Mehra N, Rivoltini L, Walters I, Figdor CG, Ottevanger PB, de Vries IJM (2021) Assessing the safety, tolerability and efficacy of PLGA-based immunomodulatory nanoparticles in patients with advanced NY-ESO-1-positive cancers: a first-in-human phase I open-label dose-escalation study protocol. BMJ Open 11:e050725
Article PubMed PubMed Central Google Scholar
Cui F, Qian F, Zhao Z, Yin L, Tang C, Yin C (2009) Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles. Biomacromolecules 10:1253–1258
Article CAS PubMed Google Scholar
Cui X, Cao D, Qu C, Zhang X, Zheng A (2013) A study of the chemical and biological stability of vasoactive intestinal peptide. Drug Dev Ind Pharm 39:1907–1910
Article CAS PubMed Google Scholar
Dacoba TG, Omange RW, Li H, Crecente-Campo J, Luo M, Alonso MJ (2019) Polysaccharide nanoparticles can efficiently modulate the immune response against an HIV peptide antigen. ACS Nano 13:4947–4959
Article CAS PubMed PubMed Central Google Scholar
Doktorovova S, Souto EB, Silva AM (2014) Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers—a systematic review of in vitro data. Eur J Pharm Biopharm 87:1–18
Article CAS PubMed Google Scholar
Doktorovova S, Kovacevic AB, Garcia ML, Souto EB (2016) Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: current evidence from in vitro and in vivo evaluation. Eur J Pharm Biopharm 108:235–252
Article CAS PubMed Google Scholar
Durán-Lobato M, López-Estévez AM, Cordeiro AS, Dacoba TG, Crecente-Campo J, Torres D, Alonso MJ (2021) Nanotechnologies for the delivery of biologicals: historical perspective and current landscape. Adv Drug Deliv Rev 176:113899
Eldor R, Arbit E, Corcos A, Kidron M (2013) Glucose-reducing effect of the ORMD-0801 oral insulin preparation in patients with uncontrolled type 1 diabetes: a pilot study. PLoS ONE 8:e59524
Article CAS PubMed PubMed Central Google Scholar
Eldor R, Francis BH, Fleming A, Neutel J, Homer K, Kidron M, Rosenstock J (2023) Oral insulin (ORMD-0801) in type 2 diabetes mellitus: a dose-finding 12-week randomized placebo-controlled study. Diabetes Obes Metab 25:943–952
Article CAS PubMed Google Scholar
Fan W, Xia D, Zhu Q, Li X, He S, Zhu C, Guo S, Hovgaard L, Yang M, Gan Y (2018) Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery. Biomaterials 151:13–23
Article CAS PubMed Google Scholar
Fan X, Wang K, Lu Q, Lu Y, Liu F, Li L, Li S, Ye H, Zhao J, Cao L, Zhang H, He Z, Sun J (2022) Surface-anchored tumor microenvironment-responsive protein nanogel-platelet system for cytosolic delivery of therapeutic protein in the post-surgical cancer treatment. Acta Biomater 154:412–423
Article CAS PubMed Google Scholar
Fangueiro JF, Gonzalez-Mira E, Martins-Lopes P, Egea MA, Garcia ML, Souto SB, Souto EB (2013) A novel lipid nanocarrier for insulin delivery: production, characterization and toxicity testing. Pharm Dev Technol 18:545–549
Article CAS PubMed Google Scholar
FDA (2022) Drug approvals and database, https://www.fda.gov/drugs/development-approval-process-drugs/drug-approvals-and-databases (Accessed 30 Oct 2023)
Friedl JD, Jörgensen AM, Le-Vinh B, Braun DE, Tribus M, Bernkop-Schnürch A (2021) Solidification of self-emulsifying drug delivery systems (SEDDS): impact on storage stability of a therapeutic protein. J Colloid Interface Sci 584:684–697
Article CAS PubMed Google Scholar
Fu L, Hua X, Jiang X, Shi J (2022) Multistage systemic and cytosolic protein delivery for effective cancer treatment. Nano Lett 22:111–118
Article CAS PubMed Google Scholar
Griesser J, Hetényi G, Moser M, Demarne F, Jannin V, Bernkop-Schnürch A (2017) Hydrophobic ion pairing: key to highly payloaded self-emulsifying peptide drug delivery systems. Int J Pharm 520:267–274
Article CAS PubMed Google Scholar
Gurny R, Allemann E, Leroux J-C (2007) Nanoparticles for oral administration of pharmaceutical agents of low solubility. US20040018236A1
Haddadzadegan S, Dorkoosh F, Bernkop-Schnürch A (2022) Oral delivery of therapeutic peptides and proteins: technology landscape of lipid-based nanocarriers. Adv Drug Deliv Rev 182:114097
Article CAS PubMed Google Scholar
Haddadzadegan S, Knoll P, Wibel R, Kali G, Bernkop-Schnürch A (2023) Three generations of thiolated cyclodextrins: a direct comparison of their mucus permeating and mucoadhesive properties. Acta Biomater 167:309–320
Article CAS PubMed Google Scholar
Han X, Lu Y, Xie J, Zhang E, Zhu H, Du H, Wang K, Song B, Yang C, Shi Y (2020) Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions. Nat Nanotechnol 15:605–614
Article CAS PubMed PubMed Central Google Scholar
Hashim LE, Sabri AH, Athirah Mohamad M, Kurnia Anjani Q, Mustaffa MF, Abdul Hamid K (2023) Circumventing the gastrointestinal barrier for oral delivery of therapeutic proteins and peptides (PPTs): current trends and future trajectories. Curr Drug Deliv 21:211
Hu F, Hong Y, Yuan H (2004) Preparation and characterization of solid lipid nanoparticles containing peptide. Int J Pharm 273:29–35
Article CAS PubMed Google Scholar
Hu X, Fan W, Yu Z, Lu Y, Qi J, Zhang J, Dong X, Zhao W, Wu W (2016) Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery. Nanoscale 8:7024–7035
Article CAS PubMed Google Scholar
Hua S, Marks E, Schneider JJ, Keely S (2015) Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Nanomed: Nanotechnol Biol Med 11:1117–1132
Iqbal H, Yang T, Li T, Zhang M, Ke H, Ding D, Deng Y, Chen H (2021) Serum protein-based nanoparticles for cancer diagnosis and treatment. J Control Release 329:997–1022
留言 (0)